NNIT is proud to announce that its European division has secured another project with a long-term strategic partner – a global player in the life sciences industry – to support the implementation of a solution from a market-leading provider of digital solutions for the life sciences industry to manage regulatory registration processes.
This initiative is a natural extension of the highly succes
Nearly half of the respondents in NNIT’s Expectation Barometer 2023 survey place heightened integration of AI at the top of their priority list. However, prior to fully embracing AI, life sciences companies should prioritize the people and business processes that will become AI’s closest allies.
The potential benefits of an electronic Trial Master File (eTMF) system extend far beyond clinical operations. As Tróndur Ellingsgaard, Advisory Consultant at NNIT explains, a mature eTMF can enhance efficiency, foster greater collaboration across the organization, and enable informed decision-making.
Life science organizations face complex regulatory challenges, intensive audits, and robust internal process controls. With this new partnership, NNIT and Gimmal provide a well-established, compliant solution that customers operating within life sciences can rely on to manage the information lifecycle of GxP records.
Implementing an electronic Trial Master File (eTMF) system can revolutionize the way clinical trials are managed. However, as Michael Agard, Director of Clinical Consulting at NNIT, points out, the true value of eTMF lies in post-implementation management.
When talking about counterfeiting, most of us think about major consumer brands but, unfortunately, counterfeiting is also a major and growing problem within the life sciences industry – and to make matters worse, nobody knows exactly how big the problem is.
